Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticos...
Leadership
Pavel Raifeld C.F.A.
CEO & Director
Stephen Basso M.B.A.
Chief Financial Officer
Marianne Zhen CPA
Chief Accounting Officer & Secretary
Patricia M. Drake
Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.
